Venture In The South

S4:E193 David covers The Venture Update and then Paul interviews Dan Haight, an experienced Investor who tells his personal story of Angel Investing, what works for him and what doesn’t. (interview recorded 9.23.25)

Mothering Across ContinentsSM (MAC) a 501c3 non-profit

Support the show

Follow David on X at https://x.com/DGRollingSouth

Connect On LinkedIn with David at https://www.linkedin.com/in/davidgrisell/

Follow Paul on X at https://x.com/PalmettoAngel

Connect On LinkedIn with Paul at

https://www.linkedin.com/in/paulclarkprivateequity/

We invite your feedback and suggestions at www.ventureinthesouth.com or email [email protected].

S4:E192 David covers The Venture Update and then interviews Runbin Dong, Founder of Scale Social, an innovative social marketing platform that harnesses short video format testimonials for multisite service businesses. Scale Social validates authentic customer reviews while avoiding fake reviews and doesn't require customers to provide personal information. It has gained significant market traction in the first year of operation and successfully closed a Seed Round of financing. (discussion recorded 9.30.25)

Support the show

Follow David on X at https://x.com/DGRollingSouth

Connect On LinkedIn with David at https://www.linkedin.com/in/davidgrisell/

Follow Paul on X at https://x.com/PalmettoAngel

Connect On LinkedIn with Paul at

https://www.linkedin.com/in/paulclarkprivateequity/

We invite your feedback and suggestions at www.ventureinthesouth.com or email [email protected].

S4:E191 David gives the Weekly Update on Venture and then guest co-host Josh Miller, CEO of Gradient Health which is a data provider for Medical AI Model developers, joins David in a wide ranging discussion of what is AI, where is it going, what works about it and what doesn't, and how will it make money. (discussion recorded 9.23.25)

David's Consumer Directed Healthcare (CDH) solution White Paper

Support the show

Follow David on X at https://x.com/DGRollingSouth

Connect On LinkedIn with David at https://www.linkedin.com/in/davidgrisell/

Follow Paul on X at https://x.com/PalmettoAngel

Connect On LinkedIn with Paul at

https://www.linkedin.com/in/paulclarkprivateequity/

We invite your feedback and suggestions at www.ventureinthesouth.com or email [email protected].

S4:E190 David summarizes The Weekly Insights in Venture and then gets an update on HealthyCell from CEO Doug Giampapa. 

HealthyCell is a neutraceutical provider of a proprietary supplement gel that is easier to swallow than multiple pills and provides far better absorption. Doug updates listeners on their current primary channel, DTC with metrics. He also talks about aspirations to gradually develop a national retail presence. Then finally, Doug talks a bit about his own startup investing and how he does it. (interview recorded 9.18.25)

Rodney Brook's post on Humanoid Robots

David's comparison of StableCoins and Real World Asset (RWA) Tokens

Support the show

Follow David on X at https://x.com/DGRollingSouth

Connect On LinkedIn with David at https://www.linkedin.com/in/davidgrisell/

Follow Paul on X at https://x.com/PalmettoAngel

Connect On LinkedIn with Paul at

https://www.linkedin.com/in/paulclarkprivateequity/

We invite your feedback and suggestions at www.ventureinthesouth.com or email [email protected].

S4:E189 David covers The Weekly Insights into Venture and then David and Paul discuss the Good, the Bad and the Ugly in the Startup exits we’ve had this year. It’s the goal of every startup investment to exit for a princely sum but the journey is frequently a winding path with many detours, hopefully leading to an attractive reward at the end of the journey. (interview recorded 9.12.25)

The Jeremy Blum article from Seeking Alpha on AI Valuations

Support the show

Follow David on X at https://x.com/DGRollingSouth

Connect On LinkedIn with David at https://www.linkedin.com/in/davidgrisell/

Follow Paul on X at https://x.com/PalmettoAngel

Connect On LinkedIn with Paul at

https://www.linkedin.com/in/paulclarkprivateequity/

We invite your feedback and suggestions at www.ventureinthesouth.com or email [email protected].

S4:E188 David covers The Weekly Insights into Venture and then Paul interviews Grady Johnson, Executive Director at The Harbor Entrepreneur Center in Charleston, SC. He talks about the dramatic growth of the startup ecosystem in Charleston, the kind of companies they attract, their Mentors and how Harbor supports them. (interview recorded 9.4.25)

Rebecca Szkutak's article on The Golden Age of Robotics at TechCrunch

Support the show

Follow David on X at https://x.com/DGRollingSouth

Connect On LinkedIn with David at https://www.linkedin.com/in/davidgrisell/

Follow Paul on X at https://x.com/PalmettoAngel

Connect On LinkedIn with Paul at

https://www.linkedin.com/in/paulclarkprivateequity/

We invite your feedback and suggestions at www.ventureinthesouth.com or email [email protected].

S4:E187 David covers The Weekly Insights into Venture and then interviews Tacilent.ai CEO Ron Johnson. Tacilent is an AI-native enterprise risk management platform that turns risk management into continuous resilience with predictive risk intelligence. They came out of Stealth in September of ‘24 and are on track to hit over $1M in ARR by Q1 of ‘26. They have bootstrapped this growth to date and were recognized this year as one Georgia’s top 40 most innovative companies. Ron explains the business, their market and what the future looks like for Tacilent. If you’re an accredited investor and would like a warm intro to Ron, just reach out to me. (interview recorded 8.26.25)

WSJ article “Data Centers That Don’t Exist Yet Are Already Haunting the Grid”

Support the show

Follow David on X at https://x.com/DGRollingSouth

Connect On LinkedIn with David at https://www.linkedin.com/in/davidgrisell/

Follow Paul on X at https://x.com/PalmettoAngel

Connect On LinkedIn with Paul at

https://www.linkedin.com/in/paulclarkprivateequity/

We invite your feedback and suggestions at www.ventureinthesouth.com or email [email protected].

S4:E186 David covers The Weekly Update in Venture followed by David and Paul's review the 2025 Angel Funders Report from an investor perspective. We talk about what the data in the report means, what is not there, what we would like to see in the future and how this data influences Seed Stage Startup Investing. (interview recorded 8.26.25)

The ACA's 2025 Angel Funder's Report

Support the show

Follow David on X at https://x.com/DGRollingSouth

Connect On LinkedIn with David at https://www.linkedin.com/in/davidgrisell/

Follow Paul on X at https://x.com/PalmettoAngel

Connect On LinkedIn with Paul at

https://www.linkedin.com/in/paulclarkprivateequity/

We invite your feedback and suggestions at www.ventureinthesouth.com or email [email protected].

S4:E185 David provides The Weekly Update in Venture and then Paul interviews John Harbison, a Board Member of the Angel Capital Association and early advocate for hard data for startup investing. 

Paul and John discuss some of the highlights from the ACA's 2025 Angel Funders Report. Next week, Paul and I will share our own insights from the report in Part 2 on The Angel Funder's Report and discuss how the report helps Angels invest smarter. (interview recorded 8.11.25)

Support the show

Follow David on X at https://x.com/DGRollingSouth

Connect On LinkedIn with David at https://www.linkedin.com/in/davidgrisell/

Follow Paul on X at https://x.com/PalmettoAngel

Connect On LinkedIn with Paul at

https://www.linkedin.com/in/paulclarkprivateequity/

We invite your feedback and suggestions at www.ventureinthesouth.com or email [email protected].

S4:E184 David provides The Weekly Update in Venture and then Paul interviews Adovate CEO William Stilley about their innovative drug development platform to exploit adenosine receptors involved in multiple major diseases. He explains their strategy of focusing on a single drug candidate with favorable physiochemical characteristics and distribution kinetics that treats a common disease with few to no side effects. They will be initiating their phase II trial of their candidate drug this year and if successful, will plan to sell the drug to a major Pharma company. (interview recorded 8.6.25)

The Data Center Power post by Tyler Norris, a Power Systems expert, in his Power & Policy Newsletter

Support the show

Follow David on X at https://x.com/DGRollingSouth

Connect On LinkedIn with David at https://www.linkedin.com/in/davidgrisell/

Follow Paul on X at https://x.com/PalmettoAngel

Connect On LinkedIn with Paul at

https://www.linkedin.com/in/paulclarkprivateequity/

We invite your feedback and suggestions at www.ventureinthesouth.com or email [email protected].